Latest Investments News

Atlas Pearls reported increased pearl harvest and sales volumes for FY25, driving revenue growth to $44.3 million, though profits declined compared to the previous year. The company declared a fully franked final dividend, underscoring its solid financial footing.

Cettire Limited reported FY25 results showing stable sales revenue and a breakeven adjusted EBITDA despite a challenging luxury goods market. The company’s strategic focus on profitability, supply chain expansion, and emerging markets diversification underpins its resilience.

Cettire Limited reported stable revenue for FY25 despite a challenging luxury market, but profitability sharply declined due to increased promotional activity and softer demand.

Echelon Resources reports a robust 34% revenue increase and 26% production growth for FY2025, driven by expanded stakes and drilling success at the Mereenie field. The company balances strong cash flow with strategic reinvestment and a modest dividend.

Echelon Resources Limited reported a robust financial year ending June 2025, driven by strategic asset acquisitions and strong commodity prices, delivering a 34% revenue increase and a near 20-fold jump in net profit after tax.

Atlas Pearls Ltd reported a 6% revenue increase to $44.3 million in FY25 despite a 30% drop in net profit, unveiling a strategic roadmap targeting up to 50% production growth by FY30 alongside a fully franked dividend.

Civmec Limited posted solid FY25 results with $810.6 million revenue and a strategic acquisition boosting its naval shipbuilding footprint. The company’s $1.25 billion order book and focus on low-carbon sectors set the stage for growth.

Civmec Limited reported solid FY2025 financials with revenue surpassing A$810 million and a strengthened order book of A$1.25 billion, underpinned by its strategic acquisition of Luerssen Australia.

Experience Co Limited reports a robust FY25 with revenue growth and a significant jump in earnings, driven by a tourism rebound in Australia and New Zealand.

Cynata Therapeutics reported a $9.39 million net loss for FY2025, slightly improved from the prior year, while progressing multiple clinical trials with key results expected in 2026. The company maintains a solid cash position and funding runway through mid-2026, supported by recent capital raises and an equity subscription agreement.

Experience Co Limited reported a 6% increase in revenue to $134.3 million for FY25, alongside a 34% rise in underlying EBITDA to $19.3 million, marking its best financial performance since FY19. The company declared a fully franked dividend and initiated a 10% on-market share buy-back.

CTI Logistics reported modest revenue growth and a strong EBITDA increase in FY25, underpinned by a significant property valuation uplift and strategic capital investments. The company is poised for sustainable growth amid a consolidating freight market.